PMID: 42155673

Cost-effectiveness and budget-impact analysis of tirzepatide in heart failure with preserved ejection fraction and obesity in the German health-care system.

Estler Bent, Fröhlich Hanna, Täger Tobias, Heins Jannick, Frey Norbert, Frankenstein Lutz

International journal of cardiology · 2026

Vol. 458, pp. 134560

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.